Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interactions Between GB Virus Type C and HIV.

Sarah L. George1, Sabina Wünschmann, James McCoy

  • 1Internal Medicine, SW34-P,GH, 200 Hawkins Drive, UIHC, Iowa City, IA 52242, USA. jack-stapleton@uiowa.edu

Current Infectious Disease Reports
|November 16, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

N-terminal α-amino SUMOylation promotes phosphorylation-independent cofilin-1 translocation to the mitochondrial matrix and induces apoptosis.

Nature communications·2025
Same author

Human IgE monoclonal antibodies define two unusual epitopes trapping dog allergen Can f 1 in different conformations.

Protein science : a publication of the Protein Society·2025
Same author

Direct comparison of clear DX Nanopore and Illumina sequencing of SARS-CoV-2.

Microbiology spectrum·2025
Same author

Trained ILCs confer adaptive immunity-independent protection against influenza.

Journal of virology·2025
Same author

Characterization of Serotype-Specific Dengue Virus T-Cell Inhibition.

The Journal of infectious diseases·2025
Same author

Establishment of human post-vaccination SARS-CoV-2 standard reference sera.

Journal of immunological methods·2024
Same journal

Chagas Disease: An Opportunistic Infection in AIDS.

Current infectious disease reports·2026
Same journal

Area-based Deprivation Indices and Healthcare-Associated Infections: A Narrative Review of Evidence.

Current infectious disease reports·2025
Same journal

Next Steps: Studying Diabetic Foot Infections with Next-Generation Molecular Assays.

Current infectious disease reports·2024
Same journal

To Tweet or Not to Tweet-a Review of the Viral Power of Twitter for Infectious Diseases.

Current infectious disease reports·2024
Same journal

Web alert.

Current infectious disease reports·2024
Same journal

Bacterial Vaginosis in Postmenopausal Women.

Current infectious disease reports·2023
See all related articles

GB virus C (GBV-C) infection, though common, is not linked to disease. However, GBV-C coinfection may benefit HIV patients by improving survival and therapy response.

Area of Science:

  • Virology
  • Immunology

Background:

  • GB virus C (GBV-C), or hepatitis G virus, establishes persistent infections in 25-50% of individuals.
  • Unlike hepatitis C virus, GBV-C primarily infects lymphocytes, not hepatocytes.
  • Numerous studies have not linked GBV-C to any specific disease process.

Purpose of the Study:

  • To investigate the impact of GBV-C coinfection on HIV-infected individuals.
  • To explore potential beneficial effects of GBV-C viremia in the context of HIV.

Main Methods:

  • Review of studies on HIV-GBV-C coinfection.
  • Analysis of GBV-C's effect on HIV-related mortality and treatment outcomes.
  • In vitro studies examining GBV-C's interaction with HIV replication and cellular signaling.

Related Experiment Videos

Main Results:

  • Eight out of ten studies on HIV-GBV-C coinfection reported a beneficial effect of GBV-C viremia.
  • GBV-C coinfection was associated with reduced HIV-related mortality and improved response to therapy.
  • In vitro data suggest GBV-C may inhibit HIV replication and alter cytokine/chemokine expression.

Conclusions:

  • GBV-C coinfection may confer a survival advantage to HIV-positive individuals.
  • The mechanism may involve direct inhibition of HIV replication or modulation of the immune response.
  • Further research is needed to elucidate the precise mechanisms underlying GBV-C's beneficial effects in HIV patients.